United Therapeutics Corporation
Drug Manufacturers - Specialty & Generic
Healthcare
UTHR
48.60 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
413.34
52 week high
434.06
high
438.26
52 week low
0.00
low
413.02
growth
22.96 %
previous Close
414.73
P/E ratio
65
market cap
13.10 B
div yield
0
usd
Mar 2025
qoq
revenue
794 M
7.95 %
net incoming
322 M
6.94 %
eps
6.63 %
7.10 %
eps surprise
-0.46 %
net profit margin
40.56 %
0.00 %
operating incoming
383 M
7.02 %
net change in cash
203 M
41.45 %
cash on hand
1.90 B
11.94 %
cost of revenue
92.50 M
21.87 %
top top